AdBoards

Getting the right people in the room is one thing, asking the right questions is another story. DeciBio can do both. Maximize the insight and impact from your advisory boards with DeciBio.

Our Experts

Katie Maloney

Andrew Aijian

Schedule a Call

Related Client Results

All Client Results

Research Tools

Synthetic Oligonucleotides Market Sizing

A leader in synthetic oligonucleotide manufacturing wanted to assess the total market size and opportunity

View

No items found.

Clinical Diagnostics

IVDR Opportunity Assessment

A top-10 diagnostics company wanted to gauge preparedness and reactions to implementation of IVDR, and how that would impact a potential new product

View

Voice-of-Customer Research

Pharma & Biotech

Global Companion Diagnostic Guideline Mapping and Strategy

A large pharma new to precision oncology wanted to understand the processes and requirements to ensure that their novel CDx was included into diagnostic guidelines globally

View

Biomarker and Diagnostics Strategy

Go-to-Market Strategy

Clinical Diagnostics

Diagnostic Advisory Board

A diagnostics company requested DeciBio to help an advisory board (ad board) to understand how to position its relatively new somatic oncology genomics profiling product in an already competitive market

View

Voice-of-Customer Research

KOL Identification

Financial Services

High-Level Commercial Due Diligence in Digital Pathology

An early-stage venture firm requested a high-level commercial due diligence of a potential investment

View

Due Diligence

Clinical Diagnostics

Genetic Testing Company Assessment

A group asked DeciBio to identify and evaluate clinical genetic testing labs for potential acquisition

View

Target Identification

Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch